Wall Street's Most Accurate Analysts Say Hold These 3 Health Care Stocks With Over 4% Dividend Yields
Portfolio Pulse from Lisa Levin
Wall Street's most accurate analysts recommend holding three health care stocks with over 4% dividend yields: Pfizer Inc. (PFE), Bristol-Myers Squibb Company (BMY), and Premier, Inc. (PINC). Analysts from Morgan Stanley and Wells Fargo have maintained Equal-Weight ratings on PFE with reduced price targets. BMY saw a downgrade from BMO Capital to Market Perform and an upgrade from HSBC to Hold, with adjusted price targets. PINC maintained Neutral ratings from JP Morgan and UBS, with lowered price targets. Recent news includes FDA approvals for Pfizer's Xtandi and Bristol Myers Squibb's Augtyro, and Premier's upbeat earnings for Q1.
November 27, 2023 | 1:37 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Bristol-Myers Squibb has a dividend yield of 4.58%, with mixed analyst ratings and price target changes. FDA approval for Augtyro could be a positive driver for the stock.
The downgrade by BMO Capital is offset by the upgrade from HSBC and the recent FDA approval for Augtyro, which may support the stock price in the short term.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Pfizer Inc. maintains a high dividend yield of 5.38% with Equal-Weight ratings and reduced price targets from analysts. Recent FDA approval for Xtandi could positively impact the stock.
Despite reduced price targets, the FDA approval for Xtandi is a positive development that could counterbalance the impact of the target adjustments. The high dividend yield remains attractive to investors.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Premier, Inc. offers a 4.02% dividend yield with Neutral ratings from analysts and decreased price targets. Positive Q1 earnings could influence the stock favorably.
While the price targets have been lowered, the upbeat earnings for Q1 indicate a strong financial performance that could help maintain investor interest in the stock.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 80